Smith & Nephew plc (SNN)

Market Cap	13.82B
Revenue (ttm)	5.94B
Net Income (ttm)	491.00M
Shares Out	874.63M
EPS (ttm)	0.56
PE Ratio	58.14
Forward PE	19.83
Dividend	$0.73 (2.26%)
Ex-Dividend Date	Oct 3, 2025

Volume	535,971
Open	32.49
Previous Close	32.79
Day's Range	32.26 - 32.62
52-Week Range	23.69 - 38.79
Beta	0.66
Analysts	Hold
Price Target	32.83 (+0.86%)
Earnings Date	Mar 2, 2026

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 16, 1999
• Employees: 18,060
• Stock Exchange: NYSE
• Ticker Symbol: SNN
• Website: https://www.smith-nephew.com

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Analyst Summary

According to 4 analysts, the average rating for SNN stock is "Hold." The 12-month stock price target is $32.83, which is an increase of 0.86% from the latest price.

Price Target

$32.83

(0.86% upside)

Analyst Consensus: Hold